XML 61 R46.htm IDEA: XBRL DOCUMENT v3.24.1
SELECTED STATEMENTS OF INCOME DATA (Tables)
12 Months Ended
Dec. 31, 2023
Income Statement Related Disclosures [Abstract]  
Schedule of Research and Development Costs, Net Research and development, net:
Year Ended December 31,
202320222021
Total costs$386,745 $364,654 $319,083 
Less - grants and participations(2,441)(2,414)(2,118)
Less - capitalization of software development costs(61,596)(56,167)(45,778)
$322,708 $306,073 $271,187 
Schedule of Financial Income (Expenses) and Other, Net Financial expenses and other, net:
Year Ended December 31,
202320222021
Financial income:
Interest and amortization/accretion of premium/discount on marketable securities, net$13,813 $13,659 $13,751 
Interest income
20,260 4,720 200 
34,073 18,379 13,951 
Financial expenses:
Interest expense
(1,101)(1,127)(10,061)
Loss in respect of debt extinguishment(53)(1,206)(13,969)
Debt issuance costs amortization(2,015)(1,996)(610)
Exchangeable senior notes amortization of discount(2,600)(2,587)(5,708)
Exchange rates differences(3,297)(301)(4,131)
Other(2,412)(2,774)(2,958)
(11,478)(9,991)(37,437)
Other (expenses) Income, net(122)1,771 196 
$22,473 $10,159 $(23,290)
Schedule of Computation of Net Earnings Per Share
The following table sets forth the computation of basic and diluted net earnings per share:
1.Numerator:
Year Ended December 31,
202320222021
Net income to ordinary shareholders$338,301 $265,945 $199,223 
2.Denominator (in thousands):
Year Ended December 31,
202320222021
Denominator for basic net earnings per share:
Weighted average number of shares (thousand)63,590 63,790 63,189 
Effect of dilutive securities:
Add - employee stock options and RSU995 894 1,605 
Warrants issued in the exchangeable notes transaction1,680 1,781 2,102 
Denominator for diluted net earnings per share - adjusted weighted average shares (thousand)$66,265 66,465 66,896